PubRank

H L Robinson

Author PubWeight™ 151.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001 9.09
2 Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell 1981 8.69
3 DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 1993 4.49
4 Proteins of Rous sarcoma virus. Virology 1968 3.84
5 DNA in uninfected and virus-infected cells complementary to avian tumor virus RNA. Proc Natl Acad Sci U S A 1971 3.25
6 Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J Virol 1986 3.21
7 At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses. Proc Natl Acad Sci U S A 1982 2.84
8 Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997 2.69
9 Isolation and characterization of proteins from Rous sarcoma virus. Virology 1971 2.66
10 DNA polymerase in defective Rous sarcoma virus. Virology 1971 2.56
11 Heterogeneity of genetic loci in chickens: analysis of endogenous viral and nonviral genes by cleavage of DNA with restriction endonucleases. Cell 1979 2.55
12 C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol 2000 2.49
13 Tumor virus RNA's. Proc Natl Acad Sci U S A 1967 2.18
14 A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J Virol 1987 2.14
15 Isolation of noninfectious particles containing Rous sarcoma virus RNA from the medium of Rous sarcoma virus-transformed nonproducer cells. Proc Natl Acad Sci U S A 1967 2.13
16 Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science 1988 2.12
17 Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J Virol 1986 1.93
18 Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med 2000 1.85
19 Host Susceptibility to endogenous viruses: defective, glycoprotein-expressing proviruses interfere with infections. J Virol 1981 1.81
20 Subgroup-E avian-leukosis-virus-associated disease in chickens. Cold Spring Harb Symp Quant Biol 1980 1.79
21 Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells. J Virol 1976 1.76
22 Variation in avian retrovirus genomes. Ann N Y Acad Sci 1980 1.75
23 Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 1996 1.71
24 Production of unique C-type viruses by chicken cells grown in bromodeoxyuridine. Virology 1976 1.70
25 High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis. J Virol 1985 1.69
26 Ten genetic loci in the chicken that contain structural genes for endogenous avian leukosis viruses. Cold Spring Harb Symp Quant Biol 1980 1.63
27 Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 1995 1.59
28 Inheritance and expression of chicken genes that are related to avian leukosis sarcoma virus genes. Curr Top Microbiol Immunol 1978 1.54
29 Expression of endogenous ALV antigens and susceptibility to subgroup E ALV in three strains of chickens (endogenous avian C-type virus). Virology 1976 1.52
30 Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes. Proc Natl Acad Sci U S A 1986 1.52
31 Role of methylation in the induced and spontaneous expression of the avian endogenous virus ev-1: DNA structure and gene products. Mol Cell Biol 1982 1.48
32 Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. AIDS Res Hum Retroviruses 2006 1.47
33 The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997 1.46
34 Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 1997 1.45
35 Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res Hum Retroviruses 1998 1.41
36 Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat Biotechnol 2001 1.39
37 Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol 1998 1.39
38 Genomes of endogenous and exogenous avian retroviruses. Virology 1983 1.33
39 Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation. J Virol 2001 1.29
40 Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996 1.29
41 Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin. J Natl Cancer Inst 1971 1.27
42 Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol 1995 1.27
43 Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness. J Virol 1991 1.26
44 Long terminal repeat (LTR) sequences, env, and a region near the 5' LTR influence the pathogenic potential of recombinants between Rous-associated virus types 0 and 1. J Virol 1988 1.25
45 Influence of env and long terminal repeat sequences on the tissue tropism of avian leukosis viruses. J Virol 1988 1.24
46 Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 1999 1.22
47 Induction of angiosarcoma by a c-erbB transducing virus. J Virol 1985 1.22
48 Gs, an allele of chickens for endogenous avian leukosis viral antigens, segregates with ev 3, a genetic locus that contains structural genes for virus. J Virol 1979 1.18
49 Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J Virol 1997 1.12
50 Protection against rotavirus infections by DNA vaccination. J Infect Dis 1996 1.12
51 Avian leukosis virus-induced osteopetrosis is associated with the persistent synthesis of viral DNA. Virology 1985 1.12
52 Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Virology 1997 1.11
53 Sequences in the gag-pol-5'env region of avian leukosis viruses confer the ability to induce osteopetrosis. Virology 1985 1.10
54 Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res Hum Retroviruses 2001 1.09
55 Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques. J Virol 2001 1.09
56 Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1. J Virol 1985 1.08
57 C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2001 1.08
58 Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 1993 1.07
59 Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. J Virol 1993 1.06
60 Proteins of avian tumor viruses with different coat antigens. J Virol 1970 1.06
61 Dsi-1, a region with frequent proviral insertions in Moloney murine leukemia virus-induced rat thymomas. J Virol 1987 1.05
62 Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. Virology 1999 1.05
63 Sequences near the 5' long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis. J Virol 1986 1.04
64 Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody. J Virol 1992 1.04
65 Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry. Proc Natl Acad Sci U S A 1992 1.02
66 HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity. Virology 1997 1.00
67 DNA vaccines: a novel approach to immunization. Int J Immunopharmacol 1995 1.00
68 Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol 1988 0.99
69 Replication of Rous sarcoma virus in synchronized cells. J Gen Virol 1970 0.97
70 Low freqeuncy production of recombinant subgroup E avian leukosis viruses by uninfected V-15B chicken cells. Virology 1979 0.96
71 Protective immunity induced by rotavirus DNA vaccines. Vaccine 1997 0.96
72 Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J Virol 1995 0.95
73 DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus. J Med Primatol 2002 0.90
74 Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm). J Med Primatol 1999 0.89
75 DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. J Virol 2000 0.88
76 Susceptibility to erbB-induced erythroblastosis is a dominant trait of 151 chickens. J Virol 1985 0.88
77 V-15B, an allele of chickens for the production of a noninfectious avian leukosis virus. Virology 1979 0.88
78 DNA vaccines: a review of developments. BioDrugs 1997 0.87
79 Retroviruses and cancer. Rev Infect Dis 1983 0.87
80 DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. Vaccine 1999 0.86
81 Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. J Infect Dis 2001 0.86
82 Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein. J Virol 1996 0.85
83 Increased oncogenic potential of ErbB is associated with the loss of a COOH-terminal domain serine phosphorylation site. J Biol Chem 1992 0.84
84 Endogenous virus expression in chicken lines maintained at the Regional Poultry Research Laboratory. Virology 1979 0.84
85 New findings on the congenital transmission of avian leukosis viruses. Science 1984 0.84
86 Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics. Mol Cell Biol 1992 0.83
87 Basic mechanisms of DNA-raised antibody responses to intramuscular and gene gun immunizations. DNA Cell Biol 2000 0.81
88 Influence of avian leukosis viral sequences on transmission to the egg and embryo. Virology 1989 0.81
89 Infrequent involvement of c-fos in avian leukosis virus-induced nephroblastoma. J Virol 1990 0.81
90 Th1 genetic adjuvants modulate immune responses in neonates. Vaccine 2001 0.81
91 Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA. J Immunol 1995 0.81
92 Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. Avian Dis 1992 0.80
93 DNA vaccines against rotavirus infections. Arch Virol Suppl 1996 0.80
94 Induction of renal adenocarcinoma by a nonmutated erbB oncogene. J Virol 1993 0.80
95 Early studies on DNA-based immunizations for measles virus. Vaccine 1997 0.79
96 Role of RAV-0 genes in the permissive replication of subgroup E avian leukosis viruses on line 15Bev1 CEF. Virology 1988 0.78
97 Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine 1997 0.78
98 Replication of an osteopetrosis-inducing avian leukosis virus in fibroblasts, osteoblasts, and osteopetrotic bone. Virology 1994 0.77
99 The replication of subgroup E avian retroviruses is blocked at or before viral DNA synthesis in restrictive chicken cells. Virology 1979 0.77
100 Avian leukosis viruses and cancer: genetics of insertional mutagenesis. Prog Nucleic Acid Res Mol Biol 1983 0.76
101 Correction: copy numbers of HIV-1 RNA. Science 1990 0.75
102 Histological and histochemical observations of the megakaryocyte following ionizing x-irradiation. Exp Med Surg 1968 0.75
103 SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. Vaccine 1997 0.75
104 Genetics of leukemogenesis by avian leukosis viruses. Haematol Blood Transfus 1981 0.75
105 Murine retroviral vectors: T-cell line specific expression of a cytomegalovirus immediate early promoter. Biotechniques 1990 0.75
106 Learning to count the calories. Nurs Times 1975 0.75
107 Cancer induction by insertional mutagenesis: the role of viral genes in avian leukosis virus induced cancers. Prog Clin Biol Res 1983 0.75
108 The induction of mucosal immunity in the female genital tract using gene-gun technology. Part 1: Antigen expression. Ann N Y Acad Sci 1995 0.75
109 Genetic control of endogenous avian tumor virus expression. Bibl Haematol 1975 0.75
110 Factors in the delayed treatment of oral cancer. N Y J Dent 1967 0.75
111 Establishment of interference in osteoblasts by an osteopetrosis-inducing avian leukosis virus. Virology 1994 0.75
112 Collaborative innovations among nursing managers. Mich Nurse 1990 0.75
113 Effect of CpG methylation on isotype and magnitude of antibody responses to influenza hemagglutinin-expressing plasmid. DNA Cell Biol 1999 0.75
114 Avian lymphoid leukosis is correlated with the appearance of discrete new RNAs containing viral and cellular genetic information. Haematol Blood Transfus 1981 0.75
115 The genetic basis of retroviral-induced transformation. Curr Top Microbiol Immunol 1982 0.75